SEC Form 4 Reporting Owner · CIK 0001901282

Derek Hicks

EVP at Intellia Therapeutics Inc

Bought (12 mo) —
Sold (12 mo) —
Form 4 Filings 6
Companies 1
Filing Activity 2025-01-07 first filed 2022-01-05

Trading record

Open-market buys — 0 filings
Open-market sales −$261K 3 filings
Sales under a 10b5-1 plan 0% 0 of 3 sale filings · 1 undisclosed

Companies

Open-market shares bought and sold at each company, and the holding after the latest filing
CompanyRoleFilingsBoughtSoldNetHolding after latest filing
NTLAIntellia Therapeutics Insider tradingEVP6—12,191−12,19159,878 2025-01-07

Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.

Insider Trading History

Company Type Value Filed View filing
NTLA Intellia Therapeutics Inc Sell -$79,194 2025-01-07
NTLA Intellia Therapeutics Inc Award — 2024-03-05
NTLA Intellia Therapeutics Inc Sell -$114,216 2024-01-05
NTLA Intellia Therapeutics Inc Award — 2023-03-03
NTLA Intellia Therapeutics Inc Sell -$67,425 2023-01-06
NTLA Intellia Therapeutics Inc Award — 2022-01-05